Synthokem Labs Private Limited was set up as a Private Limited Company for the manufacturing of Bulk Drugs and Intermediates in 1978. Synthokem is an export-oriented unit. Today Synthokem exports more than 80% of the produce to France, U.S.A., U.K., Bangladesh, Egypt, Iran, Spain, Germany, Canada, Mexico, Italy, Vietnam, Australia, South America, Belgium, and South Korea etc. Milestones of SYNTHOKEM LABS : 1993: Submitted relevant DMFs to USFDA for certification of METHOCARBAMOL & GUAIFENESIN. 2000: Obtained an ISO 9001:2000 Certification from DNV (Det Norske Veritas). 2001: A CoS for GUAIFENESIN (Ph.Eur.) by the Council of Europe, European Directorate for the Quality of Medicines. 2002: Obtained WHO-GMP Certificate first time. 2005: USFDA inspected our facility in January 2005 by the and is an approved facility. 2008: ISO 9001:2000 (Quality Management System) Certification has been renewed. 2010: ISO 9001:2008 QMS Certification obtained from DNV (Det Norske Veritas). 2010: USFDA re-inspected our facility in November 2009 and approved facility. 2010: Kosher Certification obtained for Guaifenesin from Earth Kosher (Kosher Certification Agency). 2010: Received MSME - National Award in August, 2010 for Outstanding Entrepreneurship as Special Recognition Award. 2011: Received Excellence Award from FAPCCI in July, 2011 for excellence in non-conventional/renewable energy development / application.